<DOC>
	<DOCNO>NCT02194153</DOCNO>
	<brief_summary>Obtaining data efficacy ( e.g . complete ST-segment resolution ) depend time treatment initiation safety prehospital early hospital thrombolysis MetalyseÂ® real life set outside clinical trial .</brief_summary>
	<brief_title>Surveillance Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Tenecteplase</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Inclusion criterion : Male female patient suspect myocardial infarction , e.g . transportation hospital ambulance . No patient young 18 year . Possibility obtain relevant information concern indication contraindication thrombolysis patient Typical chest pain duration 30 minute Definite infarction sign 12leadECG STelevation &gt; 0.1 millivolt ( mV ) &gt; 2 lead recent leave bundle branch block typical clinical sign Symptom onset &lt; = 6 hour Exclusion criterion : Patients older 75 year ( exception : patient appear much young ) Low body weight No person 18 contraindication accord summary product characteristic ( SPC ) Metalyse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>